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Objective: Traditional therapies for arteriosclerotic disease often fail as a result of an exaggerated fibroproliferative
response (recurrent stenosis) at the site of the intervention. Lysyl oxidase, secreted by activated vascular smooth muscle
cells and fibroblasts, catalyzes a key step in the cross-linking and stabilization of collagen and elastin in the vascular wall.
We hypothesized that lysyl oxidase messenger RNA (mRNA) and protein expression are time-dependent and precede
collagen accumulation and luminal narrowing after arterial balloon injury in the rat.
Methods: A 2F balloon-tipped catheter was used to injure the right common carotid artery in male Sprague-Dawley rats.
Injured right and control (uninjured) left common carotid arteries were harvested at 0, 0.25, 1, 3, 7, 14, 21, 28, and 60
days for mRNA quantitation and immunohistochemical analysis. Steady-state lysyl oxidase mRNA levels were quanti-
tated with real-time reverse transcription polymerase chain reaction (TaqMan). Immunohistochemical staining with
antibodies to –smooth muscle cell actin and lysyl oxidase, and Movat pentachrome staining were performed for
qualitative assessment of changes in the cellular and extracellular matrix components of the vessel wall. Post-injury
intimal area was measured from hematoxylin and eosin–stained specimens at each time point.
Results: When compared with sham-operated control arteries, lysyl oxidase expression in balloon-injured arteries
increased significantly to 212% by day 3 after injury, and remained elevated through day 21, with a decrease toward
baseline levels by day 28. Lysyl oxidase protein expression did not peak until day 14, and persisted through day 28.
Collagen accumulation peaked at day 28, corresponding to the maximal increase in intimal area, with later accumulation
of proteoglycans and ground substance in the intimal lesion.
Conclusion: Our results indicate that lysyl oxidase mRNA and protein expression is time-dependent after balloon injury
of the rat carotid artery and that expression appears to precede maximal collagen accumulation and corresponding
increases in intimal area. This suggests that lysyl oxidase may have an important role in stabilization of collagen and
elastin at sites of vascular injury and that modulation of lysyl oxidase activity may be a viable method to prevent or reduce
recurrent stenosis. (J Vasc Surg 2004;40:123-9.)
Clinical Relevance: Failure of traditional therapies for ischemic arteriosclerotic disease is often due to an exaggerated
fibroproliferative response (recurrent stenosis) at the site of intervention. Recurrent stenosis can be viewed as an
injury-repair process, with an initial stage characterized by cellular proliferation followed by deposition of extracellular
matrix. This study focuses on lysyl oxidase, a key enzyme involved in stabilization of collagen and elastin. This study
demonstrates that lysyl oxidase messenger RNA and protein expression are time-dependent, preceding collagen accumu-
lation and corresponding increases in intimal area. Accumulation of extracellular matrix is a major factor in growth of the
restenotic lesion, and modulation of lysyl oxidase activity may offer a therapeutic method for decreasing or preventing
recurrent stenosis.Traditional therapies for arteriosclerotic narrowing of
coronary and peripheral arteries include catheter-based ap-
proaches, such as balloon angioplasty with or without
stenting, and standard open surgical approaches, including
endarterectomy and bypass. Failure of these therapies is
often the result of an exaggerated fibroproliferative re-
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doi:10.1016/j.jvs.2004.02.028sponse at the site of intervention. Recurrent narrowing or
restenosis occurs after as many as 50% of catheter-based
therapies and 30% to 50% of traditional open procedures.1,2
The fibroproliferative response in the blood vessel wall after
arterial injury is characterized initially by cellular migration
and proliferation and subsequently by extracellular matrix
deposition.3 Exhaustive basic and clinical research has fo-
cused on vascular smooth muscle cell (SMC) migration and
proliferation.4 Comparatively little research has focused on
the extracellular matrix response characterized by deposi-
tion of collagen, elastin, and ground substances.5,6
Lysyl oxidase is a copper-dependent metalloenzyme
produced by activated SMCs and fibroblasts. This enzyme
has a vital role in the extracellular cross-linking and stabili-
zation of collagen and elastin in response to injury in a
variety of other tissues.7 Arterial balloon injury of the rat
common carotid artery is a well-established model of the
cellular component of the fibroproliferative response to123
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senger RNA (mRNA) and protein expression are time-
dependent and precede collagen accumulation and luminal
narrowing after arterial balloon injury of the rat carotid
artery.
MATERIAL AND METHODS
Animal model. A previously described model of rat
carotid artery balloon injury was used to study the time
course of lysyl oxidase expression.4 In brief, a 2F balloon-
tipped embolectomy catheter (Edwards Lifesciences) was
used to produce an endothelial denudation and stretching
injury of the common carotid artery in male Sprague Daw-
ley rats (Harlan, Inc). Animals were killed at 0, 0.25, 1, 3, 7,
14, 21, 28, 60, and 120 days, and injured right and
uninjured left common carotid arteries were harvested for
mRNA quantitation or histochemical evaluation. For
mRNA quantitation, carotid arteries were harvested and
placed in RNAlater solution (Qiagen). For histochemical
analysis, the carotid arteries were perfusion-fixed with 10%
formalin and further fixed by immersion in 10% formalin
after harvest. Sham surgeries were performed in separate
rats at 0, 3, 7, 14, 21, and 28 days. All experiments were
approved by the William Beaumont Hospital Animal Care
Committee, and complied with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.9
Lysyl oxidase mRNA quantitation. Quantitative re-
verse transcriptase polymerase chain reaction (RT-PCR)
was used to determine changes in steady-state lysyl oxidase
mRNA expression, with the TaqMan 7000 system (Applied
Biosystems). The instrument detects fluorescence released
during PCR in proportion to initial mRNA concentration,
with a fluorescent-labeled probe specific for the gene of
interest, and records the data in real time.8,10 Isolated rat
carotid arteries were stored in RNAlater solution at20°C
until time of RNA extraction. RNA was isolated from a
3-mm specimen of injured artery with a silica gel–based
membrane in a microspin column kit (RNeasy; Qiagen),
and complementary DNA was synthesized in triplicate with
the reverse transcriptase kit (Applied Biosystems). Quanti-
tative RT-PCR for lysyl oxidase was performed on each of
the three complementary DNA samples in duplicate with
the TaqMan 7000 Sequence Detection System (Applied
Biosystems) and Assays-on-Demand TaqMan gene expres-
sion primers or probe kits specific for rat lysyl oxidase
(Applied Biosystems).
Immunohistochemistry. Localization studies were
performed with standard immunohistochemical techniques
for both –smooth muscle actin and lysyl oxidase expres-
sion in response to balloon injury. In brief, 5-m sections
of formalin-fixed and paraffin-embedded vessel were depar-
affinized and hydrated, and immunohistochemistry was
performed with the labeled streptavidin biotin technique
(Histostain-Plus kit; Zymed Laboratories) and Nova Red
chromogen (Vector Laboratories), and counterstained
with hematoxylin, as previously described by our laborato-
ry.11 Endogenous peroxidase activity was blocked with
0.3% hydrogen peroxide in absolute methanol for 10 min-utes, followed by heat-induced antigen retrieval (DAKO)
for 20 minutes and enzyme epitope retrieval (Zymed) for
10 minutes. Primary antibodies were either a monoclonal
antibody to -SMC actin to stain for SMCs and activated
fibroblasts (prediluted; Zymed) or custom rabbit poly-
clonal antibody to rat lysyl oxidase (1:400; Zymed) to stain
for lysyl oxidase. Details of antiserum purification and
specificity testing are provided in the Additional Methods
section (online only).
Morphometric analysis and histochemical staining.
Morphometric analysis was performed to quantitatively
assess changes in arterial wall anatomy after balloon injury.
The injured section of common carotid artery was fixed in
10% formalin and embedded in paraffin, and 5-m cross-
sections were cut. Hematoxylin and eosin–stained sections
were evaluated for the extent of intimal changes with the
computer-aided Optimas image analysis software. Nonin-
jured left common carotid artery cross-sections were used
as controls. The circumference (perimeters) of the lumen,
internal elastic lamina, and external elastic lamina were
determined by tracing along the luminal surface, internal
elastic lamina, and external elastic lamina of digitized im-
ages.12,13 Intimal areas were calculated with the Optimas
software from these measurements. Movat pentachrome
staining was performed for qualitative assessment of
changes in the cellular and extracellular matrix components
of the arterial wall over time. This stain differentiates elastin
and nuclei (black); mucin, proteoglycans and ground sub-
stance (blue); cytoplasm and muscle fibers (red); actin
fibers (intense red); and collagen (yellow).
Statistical analysis. Quantitative RT-PCR was per-
formed to determine changes in steady-state mRNA ex-
pression of lysyl oxidase with the TaqMan 7000 (Applied
Biosystems). Baseline and threshold values were derived for
the collected fluorescence data, and the cycle threshold
(CT) was calculated as the cycle number, where fluores-
cence for each sample exceeds the threshold of a positive
response. Lysyl oxidase CT values were normalized with
the corresponding 18s RNA CT value to correct for the
amount of tissue processed, and an expression difference
was calculated relative to the control tissue (uninjured left
carotid artery for each rat) concentration value (CT
method).14
Statistical comparisons for mRNA expression data were
performed after relative fold increases were calculated, as
described above. Since mRNA expression is calculated rel-
ative to the uninjured contralateral artery before statistical
analysis, there is no statistical analysis comparing the in-
jured artery with uninjured contralateral control. The data
for balloon-injured animals was analyzed across 10 time
points from 0 to 120 days with one-way analysis of variance
(ANOVA). To compare data from balloon-injured and
sham-operated animals from 0 to 28 days in this model, a
two-factor main effects model (assuming no interaction)
with the factors of time point and treatment group was
fitted to these data. This analysis indicated that mRNA
expression was significantly affected only by treatment
group over this range of time points. The data were then
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factor (one-way ANOVA). Morphometric data were ana-
lyzed with two-way ANOVA, with consideration of inter-
action. Statistical analysis was performed with PROC GLM
in the SAS System for Windows, version 8.02.
RESULTS
Lysyl oxidase mRNA expression. Real-time quanti-
tative PCR (TaqMan) was used to determine time-depen-
dant changes in steady-state lysyl oxidase mRNA after
carotid balloon injury. Lysyl oxidase mRNA levels in-
creased to a maximum of 184% after balloon injury when
compared with uninjured control arteries, and 212% when
compared with sham-operated controls. Lysyl oxidase ex-
pression increased by day 3 after injury, and remained
elevated through day 21, with a decrease by day 28 toward
baseline levels (Fig 1). After balloon injury lysyl oxidase
expression changed significantly over time in this model
(P  .0133, one-way ANOVA). Sham operation on the
right common carotid artery did not result in a significant
change in lysyl oxidase mRNA expression over time points
from 0 to 28 days (Fig 1). Results of one-way ANOVA with
a reduced main effects model showed a statistically signifi-
cant increase in mean lysyl oxidase expression in the bal-
loon-injured rat carotid arteries compared with the sham-
operated rat carotid arteries (P  .0160).
Immunohistochemistry. Immunohistochemical anal-
ysis was performed for qualitative assessment and spatial
localization of lysyl oxidase expression and SMCs. In the
injured arteries there was an actin-positive cellular response
in the neointima, which increased progressively from day 7
through day 28. Expression of lysyl oxidase protein was
maximal in the neointima by 14 to 21 days, with a lower but
noticeable presence on day 28 (Fig 2). Moreover, lysyl
oxidase staining was most prominent at the luminal edge of
the neointimal lesion in the injured arteries. In the unin-
jured arteries there was a low constitutive level of staining
for lysyl oxidase protein in the SMCs of the media; how-
ever, no staining was seen in the intima.
Of interest, two-color immunohistochemistry of in-
jured arteries 28 days after injury showed that most cells in
the neointima expressed -SMC actin. In contrast, lysyl
oxidase was most strongly expressed by -actin–positive
cells primarily located adjacent to the luminal surface of the
neointimal lesion (Fig 3). Lysyl oxidase expression in the
media was mainly restricted to the perinuclear area of some
actin-positive cells. In addition, increased actin-positive
cellularity was also seen in the adventitia of injured arteries.
Immunostaining showed lysyl oxidase expression associ-
ated with most but not all cells in the adventitia from days
14 to 60 after injury. Two-color immunohistochemistry on
specimens 28 days after injury showed that most cells in the
adventitia stained positively for both -SMC actin and lysyl
oxidase (data not shown).
Morphometric analysis and histochemical staining.
Morphometric analysis was performed to assess changes in
arterial wall anatomy after balloon injury. The injured
arteries showed measurable increases in intimal area at day7, with an early increase in cellularity and maximal increases
in intimal area by day 28 (Fig 4). The intimal area increased
significantly over time (P  .0001, two-way ANOVA).
There were no significant changes in mean lumen, internal
elastic lamina, or external elastic lamina perimeters over
time in the uninjured left carotid arteries. There was a
decrease in lumen perimeter in the injured arteries, with a
statistically significant decrease in lumen perimeter on day
28 (P  .001, two-way ANOVA).
Movat pentachrome staining was performed for quali-
tative assessment of changes in the cellular and extracellular
matrix components of the arterial wall over time. Staining
showed SMCs in the neointima through day 21 after injury.
Collagen accumulation was seen in the intima beginning at
day 21, and reached a maximum by day 28. A reduction in
collagen with an associated increase in mucin, proteogly-
cans, and ground substance was noted by day 60 and
persisted through day 120 (Fig 5).
DISCUSSION
Failure of traditional therapies for ischemic arterioscle-
rotic disease is often the result of an exaggerated fibropro-
Fig 1. Steady-state lysyl oxidase mRNA expression after balloon
injury of the rat carotid artery or sham operation. Injured right and
uninjured left common carotid arteries were harvested at 0, 0.25,
1, 3, 7, 14, 21, 28, 60, and 120 days after injury; sham-operated
right and uninjured left common carotid arteries were harvested at
0, 3, 7, 14, 21, and 28 days after injury, and lysyl oxidase expression
was evaluated with TaqMan reverse transcription polymerase chain
reaction. In balloon-injured arteries levels were elevated to 184% of
those in the contralateral uninjured artery by 3 days after injury
(P  .0133, one-way analysis of variance). Elevated mRNA
expression continued in a broad peak until 21 days, after which
expression levels returned to and below those in the contralat-
eral uninjured artery through 120 days. Data are expressed as
mean  SEM; n  5 animals for all time points except day 3 (n
 8) and day 21 (n  7). Expression is not significantly altered
in sham-operated rat carotid arteries compared with contralat-
eral control arteries. Data are expressed as mean  SEM; n  2
animals at each time point. There is a statistically significant
increase in mean lysyl oxidase expression in balloon-injured vs
sham-operated rat carotid arteries (P .0160, one-way analysis
of variance).
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intervention. Recurrent stenosis can be viewed as an injury-
repair process, with an initial stage characterized by cellular
proliferation followed by deposition of extracellular ma-
trix.3 Much research has focused on the manipulation of
the cellular proliferation phase of this fibroproliferative
response, using pharmacologic, genetic, and irradiation
methods.15-17 In contrast, the present study focused on the
extracellular matrix response, specifically on a key enzyme
involved in the stabilization of collagen and elastin. When
viewed from this perspective, it is not unreasonable to
hypothesize that lysyl oxidase expression after arterial injury
should be time-dependent, preceding collagen accumula-
tion, as has been demonstrated in other models of acute
injury.18,19
This study demonstrates that lysyl oxidase mRNA and
protein expression are time-dependent after arterial balloon
injury in the rat carotid artery, and appear to precede
maximal collagen accumulation and corresponding in-
creases in intimal area. Specifically, lysyl oxidase mRNA
expression in the arterial wall increased nearly twofold
when compared with uninjured control arteries by day 3,
and remained elevated through day 21, with a gradual
decrease to baseline levels by day 28. Immunohistochemi-
cal studies documented increased expression of lysyl oxi-
Fig 2. Qualitative determination of lysyl oxidase express
artery over time. Immunohistochemical staining of repre
oxidase and the labeled streptavidin biotin technique w
Positive staining for lysyl oxidase in the intima is seen at th
layers of the hyperplastic intima at days 14 and 28 after in
protein expression is seen in the intima. A minimal amou
smooth muscle cells in the media of all sections, including
40.)dase protein in the neointima, which reached a maximum
by day 14 and persisted through day 28. In contrast,
maximal collagen accumulation occurred at day 28, corre-
sponding to the maximal increase in intimal area.
In this model, lysyl oxidase expression appeared to be
most prominent at the luminal edge of the growing neoin-
timal lesion after arterial injury. Of interest, in addition to
the observed changes in lysyl oxidase protein expression in
the neointimal lesion, we also observed significant expres-
sion of lysyl oxidase by actin-positive cells in the adventitia.
This may have implications for the negative remodeling
processes that have been observed in the arterial wall after
arterial injury. These remodeling pathways are known to be
transforming growth factor–dependent.13 Together with
the results of previous studies from our laboratory and
other studies that document transforming growth factor–
mediated effects on lysyl oxidase gene expression, the re-
sults of the present study suggest a variety of roles for lysyl
oxidase in the biology of arterial injury and repair.13,20-23
To our knowledge, no previous studies have character-
ized lysyl oxidase expression after arterial balloon injury.
However, in other tissues there are studies that suggest that
lysyl oxidase expression precedes collagen accumulation
after injury. For example, in a rat model of full-thickness
skin injury, lysyl oxidase mRNA levels reach a maximum by
balloon-injured and contralateral uninjured rat carotid
tive sections with a custom polyclonal antibody to lysyl
ova Red chromogen and hematoxylin counterstaining.
inal edge and within the smooth muscle cell–containing
arrows). By 60 days only a scant amount of lysyl oxidase
constitutive protein expression is found surrounding the
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approximately day 22 after injury.18 Similarly, after bleo-
mycin-induced lung injury, lysyl oxidase activity is in-
creased by day 3, whereas maximal collagen and elastin
accumulation does not occur until day 28.19 We hypothe-
sized that lysyl oxidase expression is similarly time-depen-
dent after arterial balloon injury in the rat. The results of
these experiments demonstrate that lysyl oxidase mRNA
and protein expression are time-dependent and precede
collagen accumulation, similar to that observed after injury
in other tissues. The apparent antecedent expression of lysyl
oxidase before SMC migration or proliferation in the
present study is an interesting observation that clearly war-
rants further exploration. We hypothesize that lysyl oxidase
expression is a necessary prerequisite for collagen (and
elastin) stabilization, and that it may indeed provide an
important regulatory pathway, not only for the expression
of other collagen-related gene products, but also for the
phenotypic modulation of activated SMCs and fibroblasts.
Detailed exploration of these hypotheses was beyond the
scope of the present study, but nonetheless provides a
fruitful area for future investigation.
As indicated by Strauss et al,5 extracellular matrix for-
mation is a major factor in the growth of the restenotic
lesion. Moreover, Wight et al24 demonstrated the accumu-
lation of proteoglycan-rich regions containing versican and
biglycan, as well as distinct collagen-rich regions in human
Fig 3. Two-color immunohistochemical localization of lysyl oxi-
dase and -smooth muscle cell actin in balloon-injured rat carotid
artery 28 days after injury. Immunostaining for -smooth muscle
cell actin was with a monoclonal antibody and Nova Red chromo-
gen (red; white arrows). Immunostaining for lysyl oxidase was with
a custom rabbit polyclonal antibody and diaminobenzidene chro-
mogen (black; black arrows). Most cells in the neointima expressed
-smooth muscle cell actin, but lysyl oxidase was most strongly
expressed by -actin–positive cells primarily adjacent to the lumi-
nal surface. Lysyl oxidase expression in the media was mainly
restricted to the perinuclear area of some actin-positive cells.
(Original magnification 40.)peripheral restenotic lesions. Similarly, other investigators
have explored the expression of matrix-related gene prod-
ucts in response to balloon injury in the present model. For
example, Nikkari et al25 showed that versican, biglycan,
collagen, and elastin mRNA increases significantly between
1 and 2 weeks after balloon injury in rat carotid artery.
Collagen and elastin mRNA expression decreased by 4
weeks in those studies, whereas proteoglycan mRNA ex-
pression remained elevated through 4 weeks after injury.25
These results are in agreement with our findings that max-
imal collagen accumulation occurs at 28 days after injury,
and proteoglycan or ground substance accumulation oc-
curs later. Similarly, Wight et al24 observed distinct regions
of proteoglycan and collagen-I accumulation in human
restenotic lesions up to 36 months after surgery. Moreover,
Strauss et al5 postulated that the delay of collagen accumu-
lation until 4 weeks after injury in the rabbit iliac balloon
injury model may be the result of degradation and turnover
of newly synthesized extracellular matrix proteins. The
results of the present study suggest that this delay may
relate, in part, to a temporal correlation with lysyl oxidase
gene expression and enzyme activity. In the absence of
sufficient lysyl oxidase activity, inadequately crosslinked
collagen and elastin are rapidly degraded.26,27 Thus further
support for this hypothesis could be provided by studies in
which the bioactivity of lysyl oxidase is specifically modu-
lated over time in this model.
A significant limitation of this study is the use of healthy
rat carotid artery, which may not be representative of the
response in the atherosclerotic vessel wall. The results of the
Fig 4. Mean maximal intimal area after balloon injury of the rat
carotid artery. Intimal area was calculated with the Optimas image
processing system from digitized photographs of hematoxylin and
eosin–stained paraffin-embedded sections of rat carotid arteries.
The injured arteries from all groups showed measurable intimal
thickening at day 7, with an early increase in cellularity and
maximal intimal area at day 28. Neointimal area decreased consid-
erably by 60 days after injury, and approached baseline values by
120 days. The intimal area differed significantly across different
days (P .0001, two-way analysis of variance). Data are presented
as mean intimal areas  SEM; n  5 animals for all time points
except days 3, 7, and 21, where n  7.
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deposition after arterial injury. In contrast to restenotic
lesions in human beings, however, early collagen accumu-
lation is not followed by persistence in this model. Thus the
role of collagen stabilization in the evolution of neointimal
lesions in this model may be significantly different from that
in diseased arteries in human beings. Given the central role
of lysyl oxidase in the cross-linking of collagen in the
extracellular matrix, it is possible that the apparent regres-
sion of neointimal collagen may relate to variations in lysyl
oxidase bioactivity and hence collagen stabilization in this
model. This may have implications for expression of the
various other collagen-related gene products after arterial
injury in human beings.
The present study does not address the central role of
specific changes in lysyl oxidase bioactivity in the stabiliza-
tion and accumulation of collagen in the persistent intimal
lesion after arterial injury. Indeed, it is possible, if not
probable, that local regulation of bioactivity is more impor-
tant in the development of a persistent neointimal lesion
than lysyl oxidase mRNA expression per se. Thus a signifi-
Fig 5. Qualitative determination of changes in cellul
balloon-injured rat carotid artery over time. Movat pentac
muscle red; actin fibers intense red; proteoglycan, groun
amounts of red staining, reflecting smooth muscle prol
arteries over time through day 21 after injury. Total coll
as intimal area decreases collagen staining is reduced an
proteoglycan and ground substance. Red staining is vis
smooth muscle cells. (All images, original magnificationcant weakness of the present study relates to the use of
relative quantitation of steady-state lysyl oxidase mRNA
levels, as opposed to specific measurement of enzyme ac-
tivity as a proxy for lysyl oxidase expression in this model. A
variety of factors can influence the final activity of this
enzyme, including mRNA stability, post-translational pro-
cessing, and metalloproteinase activity. Clearly, a better
index of lysyl oxidase expression in this model would be to
directly measure lysyl oxidase enzyme activity.20,28
Studies using a specific lysyl oxidase enzyme inhibitor,
such as 	-aminopropionitrile fumarate, will be necessary to
confirm a role for lysyl oxidase in collagen stabilization in
this model. Administration of 	-aminopropionitrile fuma-
rate both decreases stiffness in the carotid artery in young
rats and decreases recurrent stenosis after iliac artery angio-
plasty in rabbits.6,29 It would also be interesting to extend
these observations in atherogenic models, such as the hy-
percholesterolemic rabbit30 or the double-injury iliac
model in rabbits, which may more closely model clinical
arterial balloon injury.5 Future studies will explore the role
of specific modulation of lysyl oxidase expression with
mposition of the vessel wall and matrix formation in
e stains nuclei and elastin fibers black; cell cytoplasm and
stance, and mucin blue; and collagen yellow. Increasing
on, are seen in the hyperplastic intimal layer of injured
is increased at days 21 and day 28. By days 60 and 120,
reased blue staining is seen, reflecting the presence of
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sistence, as well as the complex interaction between colla-
gen, elastin, and lysyl oxidase gene expression in this model.
In conclusion, the results of the present study indicate
that lysyl oxidase mRNA and protein expression is time-
dependent and that expression appears to precede maximal
collagen accumulation and the corresponding increases in
intimal area after balloon injury in the rat carotid artery. In
addition, there appear to be regional differences in lysyl
oxidase expression, not only within the developing neoin-
timal lesion but also within the arterial wall. Given the
well-documented role of lysyl oxidase in the stabilization
and accumulation of collagen and elastin in other injury
models, it is possible that modulation of lysyl oxidase
activity may offer a therapeutic method for decreasing or
preventing recurrent stenosis. The potential of this ap-
proach is supported by previous research that demon-
strated modulation of lysyl oxidase expression and bio-
activity by cytokines, such as transforming growth
factor-	, interferon-
, interleukin-1	, and prostaglandin
E2,
20-22,28 as well as inhibition of lysyl oxidase by hepa-
rin.31 Further understanding of the complex interplay be-
tween lysyl oxidase, collagen, and elastin expression after
arterial injury may lead to new pharmacologic or genetic
methods for reducing or preventing recurrent stenosis after
vascular intervention.
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